LIGAND PHARMACEUTICALS INC (LGND) — Total Assets

Annual figures by fiscal year, from SEC filings.

2010: $75.56M2011: $120.58M2012: $104.26M2013: $104.71M2014: $258.03M2015: $503.06M2016: $601.59M2017: $671.02M2018: $1.26B2019: $1.49B2020: $1.36B2021: $1.30B2022: $762.67M2023: $787.22M2024: $941.77M2025: $1.56B$1.56B
2010Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$1.56B+65.7%
2024$941.77M+19.6%
2023$787.22M+3.2%
2022$762.67M-41.2%
2021$1.30B-4.7%
2020$1.36B-8.9%
2019$1.49B+18.6%
2018$1.26B+87.9%
2017$671.02M+11.5%
2016$601.59M+19.6%
2015$503.06M+95.0%
2014$258.03M+146.4%
2013$104.71M+0.4%
2012$104.26M-13.5%
2011$120.58M+59.6%
2010$75.56M